Singmed
Latest round
- Series B
Last raised
- Apr 2026
Total raised
- $44M
Investors
- 6
About Singmed
, dba Singmed, provides drug delivery solutions for the healthcare industry. The company was established to design and develop high quality, affordable drug delivery devices to enhance clinical efficacy for patients in China. Singmed's main products include single-dose capsule DPI (Dry Powder Inhaler) devices, multi-dose blister DPI devices, soft mist inhalation devices and multi-power nasal spray devices. Its products are used in the delivery of asthma, chronic obstructive pulmonary disease (COPD), nasal and brain diseases. The company’s revenue is generated from manufacturing complex drug delivery devices and drug-device combination products.
Who invested in Singmed
6 investors across 2 rounds
See all investors in Singmed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Singmed
Who invested in Singmed?
Singmed has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Singmed raised?
Singmed has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Singmed last raise money?
Singmed's most recent round on record is a Series B, in Apr 2026.
What does Singmed do?
, dba Singmed, provides drug delivery solutions for the healthcare industry.
Where is Singmed headquartered?
Singmed is headquartered in Suzhou, China.
Which VCs invest in companies like Singmed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Singmed's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Singmed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.